CClinicalTrials.gg
RecruitingNCT06578000IontophoresisUpdated Aug 29, 2024

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients

A Phase 1 interventional study of Magnesium sulfate and conventional therapy in Lateral Epicondylitis, sponsored by NOUR ALI ABO EL ELAA FRAGHLY. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-08-29.

Sponsored by NOUR ALI ABO EL ELAA FRAGHLY · Phase 1, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
Phase
Phase 1
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

This study is conducted To evaluate the effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis.

Read the detailed description

This study is conducted To evaluate the effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis.

BACKGROUND:

Lateral epicondylitis (LE) (tennis elbow) is a tendinopathy of the forearm extensor muscles, often caused by overuse or repetitive use (mostly of the extensor carpi radialis brevis), forced extension or direct trauma in the epicondyle . LE has an approximate rate of 40% and a prevalence of 1-3% of the general population . It mostly affects people 40 years and older. Some studies indicate that men and women are equally affected; others report a higher percentage of affected women .

HYPOTHESES

It will be hypothesized that:

There will be no statistically significant effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis.

Definition of terms Lateral epicondylitis: pain and tenderness over the lateral epicondyle of the humerus, and pain on resisted dorsiflexion of the wrist, middle finger, or both .

Iontophoresis: is a technique used to enhance transdermal penetration of substances through the application of electric current .

RESEARCH QUESTION:

This study will be conducted to answer the following question:

What is the effect of magnesium sulfate on pain intensity, muscle power, hand grip and function ability in patients with lateral epicondylitis?

02

Conditions studied

  • Lateral Epicondylitis

Browse trials for

Keywords

  • iontophoresis
03

In context

Tennis Elbow

284 studies on the registry are indexed under Tennis Elbow; 60 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 253 interventional studies indexed under Tennis Elbow.

Browse Tennis Elbow studies →

Lead sponsor

This is the only study on the registry with NOUR ALI ABO EL ELAA FRAGHLY as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • Their age will be ranged between 20-50 years with both gender

      • Pain on the lateral side of the elbow for at least 4 weeks
      • Tenderness over the lateral epicondyle
      • At least two positive provocative tests: Mill test and Thomson test

Exclusion criteria

Exclusion Criteria:

    • History of injection, surgery, physical therapy in the elbow area in the last 3 months

      • Previous elbow surgery
      • History of radius/ulna fracture
      • History of cervical and shoulder problems
      • Having bilateral symptoms
      • Concomitant medial epicondylitis
      • Malignancy
      • Pregnancy
      • Systemic rheumatologic disease or systemic infection
      • Inserted cardiac pacemaker
      • Presence of coagulation disorders
      • Cognitive dysfunction
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    group 1 ( Iontophoresis therapy (MgO4 will be applied to the active positive electrode))

    Iontophoresis therapy (MgO4 will be applied to the active positive electrode and the treatment will be repeated twice a week for four weeks) + conventional therapy (Splint + Stretch + strength).

    Drug: Magnesium sulfate · Other: conventional therapy

  • Sham comparator
    Control Group (2): conventional physical therapy treatment

    conventional therapy (Splint + Stretch + strength) twice a week for six weeks

    Other: conventional therapy

Interventions

  • DrugMagnesium sulfate

    Iontophoresis therapy (MgO4 will be applied to the active positive electrode and the treatment will be repeated twice a week for four weeks) + conventional therapy (Splint + Stretch + strength).

  • Otherconventional therapy

    conventional therapy (Splint + Stretch + strength) twice a week for six weeks

06

What researchers measure

Primary outcomes

  1. to investigate the effect of magnesium sulfate on pain intensity

    . Visual analogue scale will be used to assess the pain intensity level. Pain intensity Level will be measured using the VAS that consists of a 10-cm straight line with endpoints defining pain intensity.All patients will be asked to mark their pain level that corresponds to their pain intensity on the line between "0", representing "no pain", and "10", representing "the worst pain imaginable". The distance between "0" and the mark made by the patients was measured. Difference in pain intensity will be recorded at rest, at night, and during activity (repeated elbow movement) at baseline and after treatment

    Time frame: 6 weeks

  2. investigate the effect of magnesium sulfate on muscle power in patients with lateral epicondylitis.

    Cyriax Resisted Muscle Test: In this test, the patients will be seated and positioned with their upper extremities relaxed. The test will include elbow extension, third finger extension, pronation, and supination. All tests were conducted in a standardized manner using maximal isometric resistance and allowing no movement at either joint. Based on manual muscle testing principles, the examiner will hold the contraction for approximately 3 s to allow the patients time to build to maximum tension. The examiner will stabilize the patients' elbows with one hand and applied resistance with other hand. The patients will be instructed to report the onset of or an increase in pain. The results of the resisted tests will be recorded as "strong and painless", "strong and painful", "weak and painful", and "weak and painless". The Cyriax Resisted Muscle Test was conducted at baseline and after treatment

    Time frame: 6 weeks

  3. investigate the effect of magnesium sulfate on hand grip in patients with lateral epicondylitis.

    Maximum grip strength: by using hand dynamometer the patients will be seated on an armless chair with 90° flexion of hip and knee, their shoulders with 0° abduction and in the neutral position, their elbow at 90° flexion and their forearm in the neutral position, and their wrist in semi pronation with an upright thumb to provide a stronger grip. The protocol will consist of three maximal isometric contractions without pain for 5 s with a rest period of at least 60 s. The patients will perform three trials of grip strength using their involved and non-involved hands while maintaining 90° elbow flexion and neutral forearm position. The patients followed a verbal command of "slowly push, push, push, push, and relax" for each isometric contraction to ensure that the contractions lasted for approximately 5 s. The patients will be also asked to squeeze the dynamometer as hard as possible without the sensation of pain. The mean strength of three measurements will be recorded in kilograms

    Time frame: 6 weeks

  4. investigate the effect of magnesium sulfate on function ability in patients with lateral epicondylitis.

    The elbow functionality will be determined using the Patient-Rated Tennis Elbow Evaluation Scale (PRTEE) appendix II. The PRTEE is a 15-item questionnaire designed to measure forearm pain and disability in patients with lateral epicondylitis. The patients must rate their levels of pain and disability from 0 to 10. There are two subscales: the pain subscale (0 = no pain, 10 = worst pain imaginable) and the function subscale (0 = no difficulty, 10 = unable to do)

    Time frame: 6 weeks

Secondary outcomes

  1. Elbow range of motion

    Joint range of motion evaluation: With the wrist in neutral position, the angle achieved during maximum wrist extension was assessed using the Clinometer (Plaincode Software Solution, Stephanskirchen, Germany) which is a smartphone application. The forearm placed on the chair armrest, with 90 degrees of elbow flexion, the angle between the radius and the second metacarpal was measured by the radial styloid axis of the forearm in pronation. The interrater reliability for angular measurements was 0.76-0.95 (Lim and Shin, 2016).

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06578000
Lead sponsor
NOUR ALI ABO EL ELAA FRAGHLY
Collaborators
Cairo University
Responsible party
NOUR ALI ABO EL ELAA FRAGHLY (Lecturer assistant, Cairo University) — Sponsor-investigator
First posted
Aug 29, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Nov 30, 2024 (estimated)
Completion
Mar 2, 2025 (estimated)
Last update
Aug 29, 2024

Study contacts

nour ali abo el elaa, master
Contact
noor.ali@pt.seuz.edu.eg
01094856155
Neveen Abd El latif Abdel Raoof, professor
study director · Professor of Physical Therapy department for Basic sciences

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion